Image for Innovations in Antiviral Development and the Detection of Virus Infections

Innovations in Antiviral Development and the Detection of Virus Infections

Block, Timothy(Edited by)Crowell, Richard(Edited by)Dennison, Mark(Edited by)Jungkind, Donald L.(Edited by)Walsh, Lori R.(Edited by)
Part of the Advances in Experimental Medicine and Biology series
See all formats and editions

THE ERA OF ANTIVIRALS Introduction Although there are more than one hundred medically useful antibiotics and fungicides, there are only seven compounds licensed for use as antiviral agents, in the USA.

Some of these (acyclovir and ganciclovir) are actually derivatives of each other, making the number of new discoveries even smaller.

Moreover, most of these agents are of only limited therapeutic value and have substantial toxicity.

It has been more than 100 years ago since Pasteur studied rabies virus (2) and Rous (4) showed that a small filterable agent (not bacteria) caused disease (sarcoma) in chickens.

It was nearly 100 years ago that yellow fever virus, the first recognized human pathogenic virus, was unambiguously associated with disease (3).

Enteroviruses were cultured for the first time nearly 50 years ago (1).

Why then has effective chemotherapy against viruses lagged behind that of other microorganisms?

Viruses are often difficult to grow and image. However, with the dynamic advances in molecular biology and increased sophistication in tissue culture, the field of virology has blossomed and resulted in improved methods for detection of virus infection.

The use of viruses as models of gene regulation and replication has also resulted in a massive accumulation of information.

Read More
Special order line: only available to educational & business accounts. Sign In
£44.99
Product Details
Springer
1461534623 / 9781461534624
eBook (Adobe Pdf)
616.925
06/12/2012
English
218 pages
Copy: 10%; print: 10%